fda and compounded glp 1 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Shares Safety Data About

While patches are promising, its important to note that GLP-1 patches are still emerging in clinical trials and are not as widely available as injections

Prediction of secondary structure The engineered fusion proteins secondary structures, including the regions lacking regular shape, sections with low complexity, the proportion of random coils, extended strands, and alpha helices, were predicted by the SOPMA 64 and PORTER 65 servers

Since Ozempic is commonly prescribed for blood sugar management, it's important to be aware of how alcohol may influence your body's glucose response

While some side effects may be mild, others can be more serious